Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta at Hughes Spalding — Atlanta, Georgia

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta at Hughes Spalding is a clinical research site located in Atlanta, Georgia, United States 30303.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta at Hughes Spalding has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Sickle Cell Disease.

Sponsors: Afimmune.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta at Hughes Spalding?

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta at Hughes Spalding has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta at Hughes Spalding conducted?

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta at Hughes Spalding has 1 clinical trials on record, with 1 currently active. Their work covers Sickle Cell Disease.

Is Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta at Hughes Spalding accredited by Crixeo Health?

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta at Hughes Spalding has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta at Hughes Spalding?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.